Troglitazone-induced fulminant hepatitis: Report of a case with autopsy findings

Hong Li, Debra S. Heller, Carroll B. Leevy, Kenneth G. Zierer, Kenneth M. Klein

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Troglitazone is an insulin-sensitizing agent used to treat type 2 diabetes mellitus. Several cases have been reported of troglitazone-induced hepatic injury; some requiring transplantation, others resulting in death. We here present a case of troglitazone-induced fulminant hepatic necrosis that led to the death of the patient. (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)175-177
Number of pages3
JournalJournal of Diabetes and Its Complications
Issue number3
StatePublished - May 2000

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


  • Diabetes
  • Hepatitis
  • Troglitazone

Fingerprint Dive into the research topics of 'Troglitazone-induced fulminant hepatitis: Report of a case with autopsy findings'. Together they form a unique fingerprint.

Cite this